Anzeige
Mehr »
Dienstag, 17.06.2025 - Börsentäglich über 12.000 News
Von SOL zu BTC: Pioneer aktiviert automatisierte Bitcoin-Treasury über Kora AI Beta
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
220 Leser
Artikel bewerten:
(0)

Chi-Huey Wong Reviews the Methods of Automation in Oligosaccharides Synthesis

LA JOLLA, CA / ACCESSWIRE / June 4, 2019 / One of the most important classes of biomolecules, oligosaccharides are involved in a variety of biochemical processes, including cell differentiation, proliferation and adhesion, inflammation and immune responses. However, it is often difficult or even impossible to isolate these carbohydrate structures from natural sources, and as a result chemical synthesis has been utilized as a powerful tool in order to furnish sufficient amounts of pure oligosaccharides for biological evaluation and vaccine production. In an effort to improve upon the classical solution phase synthesis, which is a time-consuming task that often requires a special strategy for each molecule, scientists like Chi-Huey Wong are studying automated synthetic methods that can help speed up the pace of carbohydrate research by improving researchers' access to synthetic glycans.

Wong explained that alternative approaches have been investigated for some time now, beginning with solid phase synthesis, which was first reported on by Peter Seeberger in 2001. These early automated syntheses were performed successfully in a modified ABI peptide synthesizer with features adapted for carbohydrate chemistry, and with the help of that setup, it became clear that the process reduced the expenditure of time dramatically. Shortly thereafter, a fully automated carbohydrate synthesizer was developed, and the device proved beyond useful in obtaining complex and biologically relevant carbohydrate structures. Today, with the synthesis of glycosaminoglycans and other oligosaccharides continuing to be one of the greatest challenges for carbohydrate chemists, the automated concept continues to be studied and improved upon.

Another notable pioneer in glycoscience research, Chi-Huey Wong developed the first enzymatic method for the large-scale synthesis of oligosaccharides and glycoproteins and also the first programmable automated synthesis. "I believe we were the first to publish the programmable one-pot synthesis of oligosaccharides in 1998," says Wong, who is currently Scripps Family Chair Professor of Chemistry at the Scripps Research Institute in La Jolla, California. He also holds a joint appointment as distinguished research fellow at Academia Sinica in Taiwan. "This is the first kind of automated synthesis, as it involved the use of a computer program (designed by AI and machine learning) to guide the synthesis. The most recent publications from our group in this area includeis the "Hierarchical and programmable one-pot synthesis of oligosaccharides" published in Nature Communication (2018, 9, 5202) and 'Programmable one-pot synthesis of heparin pentasaccharides enabling access to regiodefined sulfate derivateves' which was published in Chemical Science."

Chi-Huey Wong is a Taiwanese-born American chemist known for his expertise in bioorganic and synthetic chemistry, especially in regards to carbohydrates and chemical biology. He was elected as a member of Taiwan's Academia Sinica in 1994, the American Academy of Arts and Sciences in 1996, and the United States National Academy of Sciences in 2002 due to his research achievements. As a result of his development of carbohydrate-based vaccines for the treatment of breast cancer and other infectious diseases, homogeneous antibody glycoforms as better therapeutics and improved methods for carbohydrate and glycoprotein synthesis, Wong was awarded The American Chemical Society Award for Creaticve Work in Synthetic Organic Chemistry in 2005, the F.A. Cotton Medal for Excellence in Chemical Research in 2008, the American Chemical Society Arthur C. Cope Award in 2012, and The Wolf Prize in Chemistry in 2014.

Scripps Research Institute Chemist Chi-Huey Wong Wins Prestigious Wolf Prize: https://www.scripps.edu/news-and-events/press-room/2014/20140124wong.html

ChemBioChem: Chi-Huey Wong's 70th birthday - Wiley Online Library: https://onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1439-7633.ChiHueyWong

Contact Information:

Chi-Huey Wong

http://www.genomics.sinica.edu.tw/index.php/en/wong-chi-huey

https://www.scripps.edu/wong/

wong@scripps.edu

SOURCE: Chi-Huey Wong



View source version on accesswire.com:
https://www.accesswire.com/547782/Chi-Huey-Wong-Reviews-the-Methods-of-Automation-in-Oligosaccharides-Synthesis

© 2019 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.